24×7 Online Assistance Email researchnnnn@gmail.com WhatsApp support Hours 24×7
MD · Clinical

Psychosis & Psychopharmacology Thesis Topics for MD Psychiatry — 78+ titles

Updated November 2026 · reviewed against the current NMC / NBE curriculum

Hand-curated database of 78+ MD Psychiatry (Psychosis & Psychopharmacology) dissertation titles, each ready with objectives, synopsis structure and protocol guidance. Unlock the objectives of any title instantly, or get the complete thesis plan — no signup.

78+MD Psychiatry (Psychosis & Psychopharmacology) titles
24×7Instant objectives & thesis plans
100%Plagiarism-free, IEC-ready
Browse all 78 titles See a full thesis plan

MD Psychiatry (Psychosis & Psychopharmacology) — Thesis Title List

78 titles · instant objectives
  1. 001

    Caregiver burden and its association with sleep quality among caregivers of patients with schizophrenia

    Psychotic Disorders Prospective analytical study Clinical Spectrum / Profile
    Objective
  2. 002

    Prevalence and correlates of depression among family caregivers of patients with chronic mental illness

    Psychotic Disorders Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  3. 003

    Predictors of relapse in schizophrenia with special reference to family expressed emotion

    Psychotic Disorders Prospective analytical study Clinical Spectrum / Profile
    Objective
  4. 004

    Demographic and clinical spectrum of schizophrenia with emphasis on quality of life

    Psychotic Disorders Prospective observational study Clinical Spectrum / Profile
    Objective
  5. 005

    Spectrum of WHOQOL-BREF findings in schizophrenia and correlation with relapse

    Psychotic Disorders Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  6. 006

    Predictive value of family burden score for quality of life in schizophrenia at a tertiary care hospital

    Psychotic Disorders Hospital-based cross-sectional study Association / Correlation
    Objective
  7. 007

    Clinical spectrum of schizophrenia and association with sleep quality

    Psychotic Disorders Prospective observational study Clinical Spectrum / Profile
    Objective
  8. 008

    Depressive symptoms on the Calgary Depression Scale for Schizophrenia and their correlation with negative symptoms

    Psychotic Disorders Hospital-based cross-sectional study Diagnostic / Tool Evaluation
    Objective
  9. 009

    Comparison of long-acting injectable versus oral antipsychotics on relapse and quality of life in schizophrenia

    Psychotic Disorders Prospective comparative study Comparative / Interventional
    Objective
  10. 010

    Medication adherence and its determinants among outpatients with schizophrenia

    Psychotic Disorders Descriptive epidemiological study Community / KAP
    Objective
  11. 011

    Prevalence of comorbid substance use in schizophrenia and its association with severity of psychopathology

    Psychotic Disorders Prospective observational study Association / Correlation
    Objective
  12. 012

    Lateral ventricular enlargement on CT and its correlation with negative symptoms and treatment response in schizophrenia

    Psychotic Disorders Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  13. 013

    Comparison of BPRS and PANSS for assessment of symptom severity in schizophrenia

    Psychotic Disorders Prospective observational study Diagnostic / Tool Evaluation
    Objective
  14. 014

    Knowledge, attitude and practice regarding schizophrenia among college students at a tertiary care hospital

    Psychotic Disorders Descriptive epidemiological study Community / KAP
    Objective
  15. 015

    Stressful life events preceding relapse in schizophrenia assessed by the Presumptive Stressful Life Events Scale

    Psychotic Disorders Prospective observational study Association / Correlation
    Objective
  16. 016

    Clozapine-induced tachycardia and heart rate variability in treatment-resistant schizophrenia

    Psychotic Disorders Prospective observational study Clinical Spectrum / Profile
    Objective
  17. 017

    Plasma clozapine levels in relation to clinical response and adverse effects in schizophrenia

    Psychotic Disorders Retrospective record-based study Association / Correlation
    Objective
  18. 018

    Prevalence of metabolic syndrome in patients with schizophrenia on second-generation antipsychotics

    Psychotic Disorders Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  19. 019

    Duration of untreated psychosis and its association with six-month outcome in first-episode psychosis

    Psychotic Disorders Prospective observational study Outcome / Prognostic
    Objective
  20. 020

    Neurological soft signs in drug-naive schizophrenia and their unaffected first-degree relatives

    Psychotic Disorders Analytical cross-sectional study Association / Correlation
    Objective
  21. 021

    Insight and its relationship with medication adherence in schizophrenia

    Psychotic Disorders Hospital-based cross-sectional study Association / Correlation
    Objective
  22. 022

    Long-acting injectable versus oral antipsychotics and rehospitalisation over one year in schizophrenia

    Psychotic Disorders Prospective comparative study Comparative / Interventional
    Objective
  23. 023

    Prevalence of tardive dyskinesia and extrapyramidal symptoms in patients on long-term antipsychotics

    Psychotic Disorders Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  24. 024

    Expressed emotion in caregivers as a predictor of relapse in schizophrenia

    Psychotic Disorders Prospective analytical study Association / Correlation
    Objective
  25. 025

    Effect of add-on yoga therapy on negative symptoms and cognition in schizophrenia

    Psychotic Disorders Prospective interventional study Comparative / Interventional
    Objective
  26. 026

    Hyperprolactinaemia and sexual dysfunction in patients receiving antipsychotics

    Psychotic Disorders Hospital-based cross-sectional study Association / Correlation
    Objective
  27. 027

    Cognitive effects of bitemporal versus bifrontal electroconvulsive therapy in severe depression

    Neuromodulation & Psychopharmacology Prospective comparative study Comparative / Interventional
    Objective
  28. 028

    High-frequency rTMS over the left dorsolateral prefrontal cortex in treatment-resistant depression

    Neuromodulation & Psychopharmacology Prospective interventional study Comparative / Interventional
    Objective
  29. 029

    Transcranial direct current stimulation for persistent auditory hallucinations in schizophrenia

    Neuromodulation & Psychopharmacology Prospective interventional study Comparative / Interventional
    Objective
  30. 030

    Adverse drug reactions to psychotropic medications: a pharmacovigilance study in a psychiatry department

    Neuromodulation & Psychopharmacology Prospective observational study Clinical Spectrum / Profile
    Objective
  31. 031

    Prescribing patterns and polypharmacy among psychiatric inpatients

    Neuromodulation & Psychopharmacology Retrospective record-based study Clinical Spectrum / Profile
    Objective
  32. 032

    Antidepressant-associated hyponatraemia in elderly patients

    Neuromodulation & Psychopharmacology Prospective observational study Clinical Spectrum / Profile
    Objective
  33. 033

    Weight gain and metabolic changes over 12 weeks with olanzapine versus aripiprazole

    Neuromodulation & Psychopharmacology Prospective comparative study Comparative / Interventional
    Objective
  34. 034

    Seizure threshold and seizure quality parameters across a course of electroconvulsive therapy

    Neuromodulation & Psychopharmacology Prospective observational study Outcome / Prognostic
    Objective
  35. 035

    Ketamine-assisted versus propofol-assisted electroconvulsive therapy in depression

    Neuromodulation & Psychopharmacology Prospective comparative study Comparative / Interventional
    Objective
  36. 036

    Adherence to psychotropic medication and its determinants in severe mental illness

    Neuromodulation & Psychopharmacology Hospital-based cross-sectional study Association / Correlation
    Objective
  37. 037

    QTc prolongation in patients receiving antipsychotic medication

    Neuromodulation & Psychopharmacology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  38. 038

    Telepsychiatry versus in-person follow-up in stable severe mental illness

    Neuromodulation & Psychopharmacology Prospective comparative study Comparative / Interventional
    Objective
  39. 039

    Cognitive subgroups in first-episode schizophrenia and their association with functional outcome at six months

    Psychotic Disorders Prospective observational study Clinical Spectrum / Profile
    Objective
  40. 040

    Theory of mind deficits and their relationship with social functioning in schizophrenia

    Psychotic Disorders Hospital-based cross-sectional study Association / Correlation
    Objective
  41. 041

    Cognitive reserve and its association with neurocognitive performance in first-episode psychosis

    Psychotic Disorders Hospital-based cross-sectional study Association / Correlation
    Objective
  42. 042

    Clinical predictors of treatment resistance over one year in first-episode schizophrenia

    Psychotic Disorders Prospective observational study Outcome / Prognostic
    Objective
  43. 043

    Obsessive-compulsive symptoms in schizophrenia and their association with clozapine treatment

    Psychotic Disorders Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  44. 044

    Clinical profile and three-month outcome of acute and transient psychotic disorder

    Psychotic Disorders Prospective observational study Clinical Spectrum / Profile
    Objective
  45. 045

    Aripiprazole versus risperidone in first-episode schizophrenia: metabolic and prolactin changes over 12 weeks

    Psychotic Disorders Prospective comparative study Comparative / Interventional
    Objective
  46. 046

    Acute-course electroconvulsive therapy parameters and psychiatric readmission within one year in major depressive disorder

    Neuromodulation & Psychopharmacology Retrospective record-based study Outcome / Prognostic
    Objective
  47. 047

    Response to electroconvulsive therapy in catatonia and its clinical predictors

    Neuromodulation & Psychopharmacology Retrospective record-based study Outcome / Prognostic
    Objective
  48. 048

    Intermittent theta-burst stimulation versus high-frequency rTMS in treatment-resistant depression

    Neuromodulation & Psychopharmacology Prospective comparative study Comparative / Interventional
    Objective
  49. 049

    Prevalence of clozapine-induced constipation and sialorrhoea in patients with treatment-resistant schizophrenia

    Neuromodulation & Psychopharmacology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  50. 050

    Valproate-associated hyperammonaemia and its clinical correlates in patients with bipolar disorder

    Neuromodulation & Psychopharmacology Hospital-based cross-sectional study Association / Correlation
    Objective
  51. 051

    SSRI-associated sexual dysfunction in depression and its effect on treatment adherence

    Neuromodulation & Psychopharmacology Hospital-based cross-sectional study Association / Correlation
    Objective
  52. 052

    Add-on rTMS over the left dorsolateral prefrontal cortex for negative symptoms of schizophrenia

    Neuromodulation & Psychopharmacology Prospective comparative study Comparative / Interventional
    Objective
  53. 053

    Functional outcome on the Personal and Social Performance scale and its clinical predictors in patients with schizophrenia in symptomatic remission

    Psychotic Disorders Hospital-based cross-sectional study Association / Correlation
    Objective
  54. 054

    Symptomatic remission by Andreasen criteria at six months and its predictors in first-episode schizophrenia

    Psychotic Disorders Prospective observational study Outcome / Prognostic
    Objective
  55. 055

    Clinical profile and six-month treatment response in patients with delusional disorder at a tertiary care hospital

    Psychotic Disorders Prospective observational study Clinical Spectrum / Profile
    Objective
  56. 056

    Prediabetes and insulin resistance in drug-naive first-episode psychosis compared with matched healthy controls

    Psychotic Disorders Analytical cross-sectional study Association / Correlation
    Objective
  57. 057

    Effect of social cognition training added to treatment as usual on social functioning in clinically stable schizophrenia

    Psychotic Disorders Prospective interventional study Comparative / Interventional
    Objective
  58. 058

    Aggressive behaviour on the Modified Overt Aggression Scale and its clinical correlates among inpatients with schizophrenia

    Psychotic Disorders Prospective observational study Association / Correlation
    Objective
  59. 059

    Bone mineral density on DXA in patients with schizophrenia on long-term antipsychotics and its association with serum prolactin

    Psychotic Disorders Hospital-based cross-sectional study Association / Correlation
    Objective
  60. 060

    Clinical profile and treatment outcome of homeless persons with severe mental illness admitted to a psychiatry ward

    Psychotic Disorders Retrospective record-based study Clinical Spectrum / Profile
    Objective
  61. 061

    Disability on the Indian Disability Evaluation and Assessment Scale and its correlation with psychopathology in schizophrenia

    Psychotic Disorders Hospital-based cross-sectional study Association / Correlation
    Objective
  62. 062

    Incidence of clozapine-induced myocarditis using weekly troponin and C-reactive protein monitoring during the first four weeks of clozapine initiation

    Neuromodulation & Psychopharmacology Prospective observational study Clinical Spectrum / Profile
    Objective
  63. 063

    Add-on metformin versus lifestyle counselling alone for antipsychotic-induced weight gain over 12 weeks

    Neuromodulation & Psychopharmacology Prospective comparative study Comparative / Interventional
    Objective
  64. 064

    Right unilateral ultrabrief-pulse versus bitemporal brief-pulse electroconvulsive therapy in severe depression: response and cognitive effects

    Neuromodulation & Psychopharmacology Prospective comparative study Comparative / Interventional
    Objective
  65. 065

    Prevalence of antipsychotic-induced akathisia on the Barnes Akathisia Rating Scale and its association with suicidal ideation

    Neuromodulation & Psychopharmacology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  66. 066

    Add-on intravenous ketamine infusions in treatment-resistant depression: change in MADRS scores over two weeks

    Neuromodulation & Psychopharmacology Prospective interventional study Comparative / Interventional
    Objective
  67. 067

    Incidence and predictors of post-ictal agitation in patients receiving electroconvulsive therapy

    Neuromodulation & Psychopharmacology Prospective observational study Clinical Spectrum / Profile
    Objective
  68. 068

    Discharge readiness and its clinical and family correlates among inpatients with severe mental illness

    Psychotic Disorders Hospital-based cross-sectional study Association / Correlation
    Objective
  69. 069

    Serum brain-derived neurotrophic factor and its association with antipsychotic response at eight weeks in drug-naive first-episode schizophrenia

    Psychotic Disorders Prospective observational study Outcome / Prognostic
    Objective
  70. 070

    Oral health status on DMFT index and its behavioural correlates in patients with schizophrenia on antipsychotics

    Psychotic Disorders Hospital-based cross-sectional study Association / Correlation
    Objective
  71. 071

    Adverse effects of repetitive transcranial magnetic stimulation assessed with a structured side-effect scale in patients with depression

    Neuromodulation & Psychopharmacology Prospective observational study Clinical Spectrum / Profile
    Objective
  72. 072

    Accelerated versus standard once-daily rTMS in treatment-resistant depression: response on HAM-D at four weeks and durability at three months

    Neuromodulation & Psychopharmacology Prospective comparative study Comparative / Interventional
    Objective
  73. 073

    Early add-on active versus sham transcranial direct current stimulation with fluoxetine in adolescents with major depressive disorder: response at four weeks

    Neuromodulation & Psychopharmacology Prospective comparative study Comparative / Interventional
    Objective
  74. 074

    Bifrontal transcranial direct current stimulation versus sham stimulation on craving after detoxification in alcohol use disorder

    Neuromodulation & Psychopharmacology Prospective comparative study Comparative / Interventional
    Objective
  75. 075

    High risk of obstructive sleep apnoea on STOP-Bang and its associated factors in patients with schizophrenia spectrum disorders on long-term clozapine

    Neuromodulation & Psychopharmacology Hospital-based cross-sectional study Association / Correlation
    Objective
  76. 076

    Indications, number of sessions, response and adverse effects of electroconvulsive therapy in bipolar disorder at a tertiary care hospital

    Neuromodulation & Psychopharmacology Retrospective record-based study Outcome / Prognostic
    Objective
  77. 077

    Nurse-led lifestyle counselling versus printed information material on weight and waist circumference in outpatients receiving antipsychotics

    Psychotic Disorders Prospective comparative study Comparative / Interventional
    Objective
  78. 078

    Effect of a structured socio-vocational rehabilitation package on work performance and social behaviour in inpatients with chronic schizophrenia

    Psychotic Disorders Prospective interventional study Comparative / Interventional
    Objective

MD Psychiatry (Psychosis & Psychopharmacology) thesis — frequently asked questions

How many MD Psychiatry (Psychosis & Psychopharmacology) thesis topics are listed here?

78+ MD Psychiatry (Psychosis & Psychopharmacology) thesis topics are listed on this page, organised by subsection of the Psychiatry (Psychosis & Psychopharmacology) curriculum. Click "Get Objectives" on any title to unlock its aim, objectives and hypothesis instantly.

Do these Psychiatry (Psychosis & Psychopharmacology) topics include the objective and synopsis?

Yes. "Get Objectives" unlocks the research question, aim, primary and secondary objectives, hypothesis and outcome measures. "Full Plan" unlocks the complete synopsis: introduction, review of literature search terms, methodology, sample-size calculation, statistical plan, ethics and timeline — ready to download as Word or PDF.

Are these topics suitable for DNB, MD and FCPS Psychiatry (Psychosis & Psychopharmacology) candidates?

Yes — these Psychiatry (Psychosis & Psychopharmacology) dissertation titles are aligned with NMC, NBE and DNB Psychiatry (Psychosis & Psychopharmacology) curricula and are suitable for MD Psychiatry (Psychosis & Psychopharmacology), DNB Psychiatry (Psychosis & Psychopharmacology) and FCPS candidates alike. We can also tailor a title to your institution's preferred study design.

Can you help with synopsis writing, protocol, data analysis and journal publication?

Yes. Beyond topic selection we provide end-to-end support: synopsis writing (NMC / NBE format), IEC / IRB-ready protocol drafting, data collection forms, statistical analysis (SPSS / R / STATA), full thesis writing, plagiarism check (Turnitin), and journal publication assistance (SCOPUS, UGC-CARE, PubMed-indexed).

How fast can I get the objective for a topic?

Instantly. After payment, the objectives open on screen in under a minute and the full plan in 1–3 minutes, 24×7. You can also click "WhatsApp" on any title to talk to our team.

WhatsApp